ArticleFrontiers in pharmacology2024

BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models.

Federica Guffanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.